🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome

RecruitingNAAges 18 Years - anyAllTampere University Hospital
NCT05637294 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Carpal tunnel syndrome is a common compression neuropathy of upper extremities. Its usual symptoms are pain, numbness and tingling of fingers, which tend to be worse at night. Splinting the wrist with an external orthosis is usually a first-line treatment provided to most people with mild to moderate disease. The FINCROSS trial (randomized cross-over trial) aims to assess the effect of night-time and full-time splinting in comparison with no-treatment. It also aims to identify possible subgroups of people who would benefit from splinting, as well as assess if positive response to splinting is associated with subsequent lower need of surgery. The trial will recruit 110 people with carpal tunnel syndrome in Finland. Each participant will undergo all three treatment periods in a randomised order: 1) splinting at night-time for six weeks, 2) splinting both day and night for six weeks; and

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Clinically confirmed carpal tunnel syndrome (CTS) of any severity level (diagnostic criteria: numbness, pain or paraesthesia in the median nerve distribution area of wrist and fingers), 2. Symptom duration of CTS for at least 3 weeks, 3. No previous corticosteroid injection for CTS during last 6 months, 4. No previous surgery for CTS, 5. Aged 18 years or older, 6. Able to complete self-report questionnaires electronically, 7. Able to understand Finnish, 8. Willing to join the study and follow the study protocol instructions, 9. Sign informed consent. Exclusion Criteria: 1. Nerve root or plexus disorders that might be causing CTS mimicking symptoms (e.g., cervical radiculopathy, thoracic outlet syndrome, or whiplash associated disorders), 2. Other neurological condition affecting the function of the hand such as Multiple Sclerosis, previous nerve injury, 3. Active Rheumatoid arthritis or any other active inflammatory joint disease affecting the hand, 4. Thenar muscle atrophy, 5. Untreated hypothyroidism, 6. Known allergy to any of the splint materials (self-reported by patient), 7. Long term treatment (over 4 months) for CTS with no response, 8. Any other known reason that could prevent from participation for the study time.
💊

What it tests

  • splinting
📍

Where

6 sites
Terveystalo Kamppi
Helsinki, Finland
Hospital Nova of Central Finland
Jyväskylä, Finland
Terveystalo Jyväskylä
Jyväskylä, Finland
Mikkeli Central Hospital
Mikkeli, Finland
Tampere University Hospital
Tampere, Finland
Terveystalo Tampere
Tampere, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy